ARCHIVES

Duke Plans To Restart Three Trials Using Tumor Microarray Analysis

This article is from The Cancer Letter archive.

Vol. 36 No. 03 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

Summit Conference Reviews Leads In Leukemia, Lymphoma

January 8, 1982

NSABP Executive Committee Is Seeking Applications From Surgeons to Lead Group

July 29, 1994

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011

Senate Passes NIH Reauthorization 87-10; $2.5 Bil. Auhtority For NCI, New Line Items

April 10, 1992

Adriamycin Update Discussed At Seminar

January 10, 1975

CCOP RFA Issued; ‘Chop-Like’ Elements Permitted But Not Required; No ‘Cap’; Consortia Allowed

July 16, 1982